SecBot SecBot
COURT-RULING ·Filed Jul 13, 2026

TMCI

TREACE MEDICAL CONCEPTS, INC.
BEARISH
Impact 5/10
Horizonmonths Processed4mo ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight ▼ Bearish

The dismissal of antitrust claims is a setback but not fatal; the patent infringement case continues. Treace may amend its antitrust claims, but the court's skepticism on antitrust injury is a headwind. Monitor for any amended complaint or developments in the patent case.

DirectionBearish
Confidencehigh
Horizonmonths

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$4.44
T+0 close · Jul 14, 2026 · via day close
Latest settled
−12.39%
T+60 · $3.89
Vs SPY
−15.76%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 14 $4.44entry
  2. T+1 · 4mo ago −0.90%α −1.30% · $4.40
  3. T+5 · 4mo ago −4.73%α −4.26% · $4.23
  4. T+20 · 3mo ago +6.76%α +4.27% · $4.74
  5. T+60 · 6w ago −12.39%α −15.76% · $3.89
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The District of New Jersey granted Stryker's motion to dismiss Treace's antitrust (Sherman Act, Clayton Act, state antitrust) and tortious interference claims without prejudice, finding Treace failed to plead antitrust injury. The patent infringement claims (Counts I-XII) survive. The ruling removes a potential avenue for broad relief but does not end the litigation.

Court Ruling Details

Ruling Date
Jul 13, 2026
Court
United States District Court District of New Jersey
Court Level
District
Judge
Jamel K. Semper
Case Type
antitrust
Ruling Type
motion to dismiss
Outcome
LOSS: ruling against this company
Precedent Risk
LOW

Key Facts

  • Court granted motion to dismiss Counts XIII–XVI (antitrust and tortious interference) without prejudice.
  • Treace failed to plead antitrust injury, allegations were conclusory and only alleged harm to itself, not to competition in the TMT Bunion Systems Market.
  • Patent infringement claims (Counts I–XII) remain pending.
  • Treace may file a second amended complaint to attempt to cure the pleading deficiencies.

Financial Impact

No monetary relief ordered; dismissal without prejudice preserves ability to replead. Patent case continues with no immediate financial impact.

Risk Factors

  • Treace may fail to adequately replead antitrust injury, leading to dismissal with prejudice.
  • Patent case carries its own risks, Stryker may seek invalidity or non-infringement rulings.
  • Litigation costs and management distraction could pressure the small-cap stock.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
10% bullish (10 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-889e1f0a26-TMCI

Track record

11 reports on TMCI

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 20261d ago SC 13G Neutral 4/10 Entry $4.42 to $4.44 Now $4.44 +0.45% ▲ +0.45% +1.47% vs SPY
  2. Nov 16, 20261d ago SC 13G/A Bearish 4/10 Entry $4.42 to $4.44 Now $4.44 −0.45% ▼ −0.45% −1.47% vs SPY
  3. Nov 12, 20266d ago Court Ruling Neutral 4/10 Entry $5.27 to $4.42 Now $4.44 −15.75% ▼ −16.13% −14.22% vs SPY
  4. Nov 6, 202611d ago 8-K Neutral 4/10 Entry $4.03 to $4.78 Now $4.44 +10.17% ▲ +18.61% +16.24% vs SPY
  5. Sep 17, 20268w ago Press Release Neutral 4/10 Entry $4.49 to $4.48 Now $4.44 −1.11% ▼ −0.22% −1.77% vs SPY
  6. Aug 7, 202614w ago 8-K Mixed 6/10 Entry $4.76 to $4.67 Now $4.44 −6.72% ▼ −1.89% −1.86% vs SPY
  7. Jul 13, 202618w ago Court Ruling Bearish 5/10 Viewing Entry $4.44 to $4.40 Now $4.44 −0.00% ▲ +0.90% +1.30% vs SPY
  8. May 8, 202627w ago Press Release Bearish 7/10 Entry $2.01 to $1.94 Now $4.44 −120.90% ▲ +3.48% +3.71% vs SPY
  9. Apr 24, 202629w ago Press Release Neutral 1/10 Entry $1.98 to $1.92 Now $4.44 +124.24% ▼ −3.03% −3.19% vs SPY
  10. Apr 9, 202631w ago 8-K Mixed 6/10 Entry $1.53 to $1.81 Now $4.44 +190.20% ▲ +18.30% +18.36% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens Thu (11h 35m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Jul 14, 2026